| Meaghan Mary Canton Feder, NP | |
|
5530 Wisconsin Ave Ste 730, Chevy Chase, MD 20815-4447 | |
| (301) 951-2400 | |
| (877) 285-1490 |
| Full Name | Meaghan Mary Canton Feder |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 5530 Wisconsin Ave Ste 730, Chevy Chase, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144401571 | NPI | - | NPPES |
| P00894790 | Other | DC | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | RN1003040 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Samantha A Toerge Md Llc | 9234367194 | 4 |
News Archive
Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.
An outbreak of Dengue Haemorrhagic Fever (DHF) in Delhi, India has authorities concerned that they may be seeing the start of an epidemic.
After initially visiting a school psychologist, adolescents in the United States with a mental disorder often go to seek care from their pediatricians or family doctors.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.
New hope is on its way for the fight against breast cancer as Griffith Health Institute research aims to target the disease with immune-based therapies.
› Verified 4 days ago
| Entity Name | Washington Hospital Center Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407870124 PECOS PAC ID: 3577476266 Enrollment ID: O20040630000173 |
News Archive
Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.
An outbreak of Dengue Haemorrhagic Fever (DHF) in Delhi, India has authorities concerned that they may be seeing the start of an epidemic.
After initially visiting a school psychologist, adolescents in the United States with a mental disorder often go to seek care from their pediatricians or family doctors.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.
New hope is on its way for the fight against breast cancer as Griffith Health Institute research aims to target the disease with immune-based therapies.
› Verified 4 days ago
| Entity Name | Samantha A Toerge Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437587581 PECOS PAC ID: 9234367194 Enrollment ID: O20140123000022 |
News Archive
Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.
An outbreak of Dengue Haemorrhagic Fever (DHF) in Delhi, India has authorities concerned that they may be seeing the start of an epidemic.
After initially visiting a school psychologist, adolescents in the United States with a mental disorder often go to seek care from their pediatricians or family doctors.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.
New hope is on its way for the fight against breast cancer as Griffith Health Institute research aims to target the disease with immune-based therapies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meaghan Mary Canton Feder, NP 3613 S St Nw, Washington, DC 20007-2245 Ph: (202) 422-5903 | Meaghan Mary Canton Feder, NP 5530 Wisconsin Ave Ste 730, Chevy Chase, MD 20815-4447 Ph: (301) 951-2400 |
News Archive
Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.
An outbreak of Dengue Haemorrhagic Fever (DHF) in Delhi, India has authorities concerned that they may be seeing the start of an epidemic.
After initially visiting a school psychologist, adolescents in the United States with a mental disorder often go to seek care from their pediatricians or family doctors.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.
New hope is on its way for the fight against breast cancer as Griffith Health Institute research aims to target the disease with immune-based therapies.
› Verified 4 days ago